Ananya Sen

Patrick Grohar answers questions about symptoms, treatments and research initiatives that are being undertaken with respect to Ewing Sarcoma.

Aging-related diseases, including cancer, cardiovascular disorders and type 2 diabetes, are associated with defects in protein synthesis and folding. In a new study, researchers at the University of Michigan found that mitochondria also accumulate misfolded proteins, which kills insulin-producing β-cells of patients with type 2 diabetes.

Joshua Ong, M.D., resident physician at University of Michigan Kellogg Eye Center answers questions about how spaceflight affects vision and what protective measures astronauts use.

Brain and spinal cord tumors account for one in four childhood cancers. Although 75% of children survive for at least five years after being diagnosed, many patients have recurrent tumors that cannot be cured. Andrea Franson discusses current therapies for pediatric brain tumors, how viruses can be used to target tumor cells and the new phase 1 trial that started in May 2025.

Charlotte Dengler was diagnosed with an eye lesion that compromised her vision and underwent surgery at Kellogg to remove the lesion and now her vision is being slowly restored.

Based on former President Joe Biden's recent diagnosis, a Michigan Medicine urologists discusses routine screening procedures and treatment outcomes.

Group-3 medulloblastomas are aggressive and incurable, contributing to childhood cancer deaths. Led by University of Michigan researchers, a study identified a new target for Group-3 medulloblastomas. The results help identify new therapeutic avenues for treating these deadly tumors.

University of Michigan researchers have identified that the balance between two proteins—STAT3 and STAT5—is important for making tumors vulnerable to immune checkpoint therapy, and targeting STAT3 degradation is a potential novel cancer immunotherapy strategy.

Researchers used mouse models and studies of colorectal cancer tissues to show that loss of SOX9 gene promotes tumor progression and the pathway it regulates can be a potential target for future treatments.

Over 70 Rogel Cancer Center researchers participated in presentations, poster sessions and as session moderators at the AACR 2025 Conference in Chicago, IL.

Researchers at University of Michigan showed that the proportion of patients undergoing prostatectomy for the lowest risk type of cancer dropped over fivefold between 2010 to 2024.

Researchers investigated the combined effects of bazedoxifene and conjugated estrogens in rat models as an alternative to tamoxifen.

U-M researchers have discovered that simultaneously targeting PIKfyve and KRAS-MAPK can eliminate tumors in preclinical human and mouse models.

University of Michigan researchers have created nanodiscs that can target cholesterol levels in GBM, starving the cancer cells and increasing survival rates of the treated mice.

Physicians followed 562 patients in the U.S. and India over a three-month period to identify risk factors for eye infections that could be easily managed with early intervention.